“Evaluating the role of anti-EBV antibodies as biomarkers for the evolution of multiple sclerosis: A longitudinal study.”

This study investigates the association between anti-EBV antibodies and the progression of multiple sclerosis over time, offering important insight into their potential as biomarkers for predicting disease evolution.

Read the full article here: https://doi.org/10.1016/j.msard.2025.106695